Madura Jayatunga is a core member of Boston Consulting Group’s Health Care practice. He primarily works with biopharma clients on their R&D and innovation agenda. Since joining the firm in 2015, he has gained extensive experience in R&D, technology, digital innovation, and large-scale transformations.

Madu leads BCG’s work in AI and advanced analytics in drug discovery and development. In that capacity, he works with biopharma, biotech, and healthtech companies, as well as investors, on innovation strategy, go-to-market strategy, product development, and digital transformation topics. He has helped clients understand the impact of new innovations; define their investment strategy; and change their operating models, ways of working, technology stack, and governance to maximize the impact across their R&D organizations.


  • DPhil, Organic Chemistry, University of Oxford
  • MSc, Medicinal Chemistry for Cancer, University of Oxford
  • MSci, Natural Sciences, University of Cambridge